| Name | Title | Area of expertise |
| Ash Vaidya | Managing Partner and Co-Founder at Sanctum Capital Management | PE/VC investment in fast-growing technologies |
| Barr Dolan | Partner at Charter Life Sciences | VC investment in biotech and medcial devices |
| Bob Scharf | Director at Praxis Center | Marketing and sales in industrial products, entrepreneurship |
| Bonni Dutcher | Former Director, Medical Affairs, Strategist at Bayer Pharmaceuticals | Medical Affairs, Regulatory, Drug Development |
| Chiraag Bhadana | Pharma Marketer | Pharma Marketing, Strategy |
| Eric Liu | Executive Director at Index Capital | Medtech and Biotech VC |
| Cor Drost | President & CEO at Transonic Systems | Medical devices; entrepreneurship |
| Dave Eilers | Innovation Advisor/Practice leader at American Hospital Association; EIR at LaunchNY | Entreprenuership; innovative healthcare delivery |
| David Anderson | CEO at Brian Temp | Medical devices; entrepreneurship |
| David Fishbach | Founder and Principal at Excel Executive Business Advisors | Enterprise software; clinical trials; operations |
| David Pritchard | President of The Board of Directors at Athena Academy & 942 Market Street | Pharma and biotech; entrepreneurship |
| Frederic Barken, MD | General Parnter at Bartrip Realty | Real estate |
| Gary Grossfeld, MD | Urologic Oncologist; former development leader at Bristol Myers Squibb | Pharma and biotech |
| Gary Markin | President & CEO at GDM consulting | Strategic consulting |
| Gaurav Aggarwal | Managing Director at Vivo Capital | Pharma and biotech; PE/VC investment |
| Guido Neels | Managing Director at Essex Woodlands Health Ventures | Pharma and biotech; PE/VC investment |
| Hanson Gifford | CEO at The Foundry | Pharma and biotech; VC investment |
| Isaac Wolf | Project Manager, Takeda | Project Management, Fermentation and Purificaiton, Lab Operations |
| Ivan Wolff | Managing Director at High Times Growth Fund | Pharma and biotech; PE/VC investment |
| Jessica Flechtner | Consultant, former CSO of Genocea Biosciences | Vaccine and cell therapy; immunology; early stage company building |
| Kevin Love | Director, Head of Business Development and Operations at Arsia Therapeutics | Pharma and biotech; Business Development and Operations |
| Mary Falvey | President, Falvey Associates | Health IT; new ventures |
| Melissa Musiker | Head of Strategy, Mission North | Communication Strategy |
| Michel Kliot | Neurosurgeon and Clinical Professor | Neurosurgery; Early-stage investment |
| Pam Silverstein | Entrepreneur in Residence and Board Member, Life Changing Labs | Technology; new ventures |
| Paul Martin | Former CEO&CTO, Databound Healthcare Solutions | Healthcare technology; entrepreneurship |
| Rob Canizares | Ex-President, MSA International | Entreprenuership; General Management |
| Robert Balk | Former Managing Director and Co-Founder at Pier 70 Ventures | Corporate Venture investment |
| Robert Honneffer | Former Executive Vice President, Global Operations of Osteotech | Medical devices; operations |
| Zach Helft | Co-Founder at C. Light Technologies, Inc. | Medical deveices; entrepreneurship |